Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
UAE Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A24288
Buy Now
UAE Pharmaceutical Market Overview:
The UAE pharmaceutical market is projected to exhibit a growth rate (CAGR) of 6.7% during 2024-2032 There are various factors that are driving the market, which include rising health awareness initiatives, increasing geriatric population, favorable government initiatives, advanced healthcare infrastructure, and various technological advancements.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023 |
|
Forecast Years
|
2024-2032
|
|
Historical Years
|
2018-2023
|
| Market Growth Rate (2024-2032) | 6.7% |
UAE Pharmaceutical Market Trends:
Rising Health Awareness Initiatives
Pfizer launched a thorough education effort in the United Arab Emirates on 1 May 2024 to generate awareness about respiratory syncytial virus (RSV) and preventative actions that can be performed. Pfizer organized an educational media roundtable with the assistance of medical experts aimed to highlight the importance of RSV prevention as well as the disease's impact and symptoms. The company is trying to find and create medications that could protect people from specific illnesses. Health awareness initiatives like these are catalyzing the demand for pharmaceutical drugs in the UAE. These initiatives, driven by both government and private sector efforts, aim to educate the population about health issues, promote preventive care, and encourage healthy lifestyles. Furthermore, regular health screenings and preventive programs are promoted to detect diseases early and manage them effectively. Campaigns to increase vaccination coverage for various diseases contribute to better public health and increased pharmaceutical demand.
Increasing Geriatric Population
The older population is more likely to suffer from chronic illnesses, including diabetes, cancer, and cardiovascular problems, which is driving the demand for medicines and favorably impacting the industry. Chronic illnesses that necessitate continuous medical attention and pharmaceutical administration are increasingly common in the aged population. The elderly population tends to use healthcare services more frequently including hospital visits, regular check-ups, and specialist consultations. This increased utilization leads to higher prescription rates and medication adherence, thereby increasing pharmaceutical sales. Besides this, the wide availability of advanced medical treatments and technologies tailored for the elderly population catalyze the demand for pharmaceuticals. Major players in the market are focusing on providing more advanced drugs that are specially developed to cater to the needs of elderly individuals. The United Nations Fund for Population Activities (UNFPA) reports that the number of persons aged 60+ is anticipated to increase more than six-fold between 2020 to 2050 from around 311,000 to 2 Million.
UAE Pharmaceutical Market News:
- 23 April 2024: Two medications, Ninervilda-50 (vildagliptin 50 mg) and Vertephin (verteporfin), were introduced by Niner Pharmaceuticals LLC, a well-known pharmaceutical company. These drugs are intended to treat serious blood vessel diseases in the eye. These innovations are set to upgrade the treatment of macular degeneration and other related diseases in the UAE, Saudi Arabia, and Latino-American countries.
- 30 October 2023: Pfizer, Middle East, Russia and Africa (MERA) hosted the MERA Vaccines Summit and welcomed more than 100 physicians and healthcare professionals from around the region to Dubai, UAE. The event covered a range of communicable diseases with leading experts. International and regional experts highlighted the global and regional burden of disease and the public health impact of vaccination and summarized recommendations for vaccination for various patient populations.
UAE Pharmaceutical Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type and nature.
Type Insights:
- Pharmaceutical Drugs
- Cardiovascular Drugs
- Dermatology Drugs
- Gastrointestinal Drugs
- Genito-Urinary Drugs
- Hematology Drugs
- Anti-Infective Drugs
- Metabolic Disorder Drugs
- Musculoskeletal Disorder Drugs
- Central Nervous System Drugs
- Oncology Drugs
- Ophthalmology Drugs
- Respiratory Diseases Drugs
- Biologics
- Monoclonal Antibodies (MAbS)
- Therapeutic Proteins
- Vaccines
The report has provided a detailed breakup and analysis of the market based on the type. This includes pharmaceutical drugs (cardiovascular, dermatology, gastrointestinal, genito-urinary, hematology, anti-infective, metabolic disorder, musculoskeletal disorder, central nervous system, oncology, ophthalmology, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines).
Nature Insights:
- Organic
- Conventional
A detailed breakup and analysis of the market based on the nature have also been provided in the report. This includes organic and conventional.
Regional Insights:
- Dubai
- Abu Dhabi
- Sharjah
- Others
The report has also provided a comprehensive analysis of all the major regional markets, which include Dubai, Abu Dhabi, Sharjah, and Others.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
UAE Pharmaceutical Market Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | Billion US$ |
| Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
| Types Covered |
|
| Natures Covered | Organic, Conventional |
| Regions Covered | Dubai, Abu Dhabi, Sharjah, Others |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the UAE pharmaceutical market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the UAE pharmaceutical market?
- What is the breakup of the UAE pharmaceutical market on the basis of type?
- What is the breakup of the UAE pharmaceutical market on the basis of nature?
- What are the various stages in the value chain of the UAE pharmaceutical market?
- What are the key driving factors and challenges in the UAE pharmaceutical?
- What is the structure of the UAE pharmaceutical market and who are the key players?
- What is the degree of competition in the UAE pharmaceutical market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the UAE pharmaceutical market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the UAE pharmaceutical market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the UAE pharmaceutical industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More